AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review Post author:GIBoardReview.com Post published:June 1, 2019 Post category:Society Guidelines You Might Also Like AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease September 29, 2023 American College of Gastroenterology Guidelines: Management of Acute Pancreatitis March 8, 2024 AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review October 6, 2022
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease September 29, 2023
AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review October 6, 2022